Stacey Tarvin, MD MS

Stacey Tarvin, MD MS

Assistant Professor of Clinical Pediatrics

Phone: 317-274-2172
Email: starvin@iu.edu
699 Riley Hospital Drive, RR307
Indianapolis, IN 46202  



Pediatric Rheumatology

Areas of Interest

Clinical Research; Psychosocial effects of chronic disease on children and their families; resiliency; medical education


A lifelong Hoosier, Dr. Tarvin grew up in southeast Indiana. She completed her medical training at Indiana University and has practiced at Riley Hospital since that time. She is the associate program director for the Peditric Rheumatology fellowship and the Section Educatoin director for pediatric rheumatology. She is a fellow in the American College of Rheumatology and the American Board of Pediatrics. She is a member of the American Academy of Pediatrics, the Childhood Arthritis Rheumatology and Research Alliance and Pediatric Rheumatology Collaborative Study Group. She is married with three rambunctious children. In her spare time she enjoys cooking, travel and anything Walt Disney.

2001 BS, Eastern Kentucky University
2005 MD, Indiana University School of Medicine
2008 Internship and Pediatric Residency, Riley Hospital for Children
2011 Fellowship, Pediatric Rheumatology, Riley Hospital for Children
2011 MS, Clinical Research, Indiana University

Honors & Awards

  • Red Shoe Award, Department of Pediatrics, Riley Hospital for Children, April/May 2012
  • E. Jane Brownly Award, Department of Pediatrics, Riley Hospital for Children, 2005
  • Fellow in Travel Scholarship, American College of Rheumatology, 2009 & 2010
  • ROC MSA3 MVP Star, June 2012


Riley Hospital for Children at IU Health
Riley Outpatient Center (ROC), MSA3
705 Riley Hospital Drive, 3rd floor
Indianapolis, IN 46202

IU North Medical Center
11725 N Illinois Street, Suite 450
Carmel, IN 46032

Research & Grants

Title: A multicenter, open-label study to assess the pharmacokinetics, safety, and efficacy of Certolizumab pegol in children and adolescents with moderately to severely active polyarticular course JIA (PASCAL)

Role: Site Principal Investigator, 5% effort          Sponsor: UCB Biosciences                    2014-present


Title: Efficacy, safety, and tolerability of Tofacitinib for treatment of polyarticular course juvenile idiopathic arthritis (JIA) in children and adolescent subjects (1104)

Role: Site Principal Investigator, 7% effort          Sponsor: Pfizer                                     2016-present


Title: A long-term, open-label follow-up study of Tofacitinib for treatment of juvenile idiopathic arthritic (JIA) (1145)

Role: Site Principal Investigator, 3% effort          Sponsor: Pfizer                                     2016-present


Title: ACCeSS: Adolescent Capacity for Contraception Self Screening (ACCESS)

Role: Co-Investigator                 Sponsor: The Society for Family Planning


Title: Depression in Children and Adolescents with Rheumatologic Disease: Incidence, treatment, and outcome

Role: Co-Investigator, 3% effort Sponsor: University of Indianapolis                                 2010-present


Title: A pilot study of circulating endothelial and hematopoietic progenitor cells in children with systemic lupus erythematosus

Role: Faculty Participant                        Sponsor: Morris Green Scholarship Fund


Kesler KA, Tarvin SE, Brooks JA, Rieger KM, Lehman GA, Brown JW Thoracoscopy-Assisted Heller Myotomy for the Treatment of Achalasia: Results of a Minimally Invasive Technique. Annals of Thoracic Surgery 2004; 77:385-92.

Tarvin SE, Ballinger SH (2006). Henoch-Schonlein purpura. Current Paediatrics 2006; 16, 259-263.

Hage CA, Bowyer SL, Tarvin SE, Helper D, Kleiman MB Wheat J. Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy. Clinical Infectious Diseases. 2010;50:85-92.

Dang, Do A, Umoren RA, Tarvin SE, Heilbrunn BR , Mahajerin A., Bowyer SL . SLE in a 3-month old Male Presenting As Thrombocytopenia. Lupus 2010 Dec 10.

*Ilowite, N. T., Prather, K., Lokhnygina, Y., Schanberg, L. E., Elder, M., Milojevic, D., Verbsky, J. W., Spalding, S. J., Kimura, Y., Imundo, L. F., Punaro, M. G., Sherry, D. D., Tarvin, S. E., Zemel, L. S., Birmingham, J. D., Gottlieb, B. S., Miller, M. L., O'Neil, K., Ruth, N. M., Wallace, C. A., Singer, N. G. and Sandborg, C. I. (2014), Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology, 66: 2570–2579. doi:10.1002/art.38699

*Skeeters, ST, Taylor, NM, Raches, CM, Tarvin, SE. Influence of Psychological Factors on the Agreement Between Child, Caregiver, and Physician Ratings of Disease Severity in Rheumatologic Diseases. Families, Systems, and Health. (RESUBMITTED)

*Tarvin SE, Taylor NM, Raches CM, Hansel, JE, Macharoni LM. Prevalence of Depression and Concomitant Risk Factors in Children with Rheumatic Disease. JAMA. (SUBMITTED/Revise and resubmit)

*Thompson, Tonia and Stacey E. Tarvin. A Case of Arthritis and Parenchymal Lung Disease in a pediatric patient. Annals of American Thoracic Society. Submitted 9/30/13, request for revise and resubmit.

*Charles H Spencer, MD; Kelly Rouster-Stevens, MD; Harry L Gewanter, MD; Grant D Syerson, MD; Renee F Modica, MD; Kara M Schmidt, MD; Helen M Emery, MD; Stacey Tarvin, MD; Sandy D Hong, MD, MS; Carol B Lindsley, MD; Jennifer E Weiss, MD; Murray H Passo, MD; Kaleo C Ede, MD; Amanda Brown, MD; Kaveh Ardalan, MD; William Bernal, MD; Matthew L Stoll, MD, PhD, MSCS; Carol A Wallace, MD; Bianca A Lang, MD; Ruy Carrasco, MD; Cassyanne Agaiar, MD; Lance Feller, MD; Huyla Bulkumez, MD; Richard K Vehe, MD; Hanna Kim, MD; Heinrike Schmeling, MD; Dana M Gerstbacher, MD; Mark F Hoeltzel, MD; B Anne Eberhard, MBBS, MSc; Robert P Sundel, MD; Susan Kim, MD; Adam Huber, MD; Anjali Patwardhan, MD, MRCPCH, DCH MRCPI.MBA.MSc.  Biologic Therapies for Refractory Juvenile Dermatomyositis:  Five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.  Pediatric Rheumatology.  Accepted 2017.